Vor Biopharma Statistics

Total Valuation

Vor Biopharma has a market cap or net worth of $90.65 million. The enterprise value is $30.71 million.

Market Cap	90.65M
Enterprise Value	30.71M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Vor Biopharma has 124.85 million shares outstanding. The number of shares has increased by 2.25% in one year.

Current Share Class	124.85M
Shares Outstanding	124.85M
Shares Change (YoY)	+2.25%
Shares Change (QoQ)	+2.28%
Owned by Insiders (%)	31.92%
Owned by Institutions (%)	12.18%
Float	38.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.94
P/TBV Ratio	0.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.19, with a Debt / Equity ratio of 0.33.

Current Ratio	5.19
Quick Ratio	4.94
Debt / Equity	0.33
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -94.52% and return on invested capital (ROIC) is -48.11%.

Return on Equity (ROE)	-94.52%
Return on Assets (ROA)	-44.42%
Return on Invested Capital (ROIC)	-48.11%
Return on Capital Employed (ROCE)	-97.51%
Revenue Per Employee	n/a
Profits Per Employee	-$735,308
Employee Count	159
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.38% in the last 52 weeks. The beta is -0.21, so Vor Biopharma's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	-61.38%
50-Day Moving Average	0.90
200-Day Moving Average	0.95
Relative Strength Index (RSI)	48.46
Average Volume (20 Days)	252,906

Short Selling Information

The latest short interest is 1.33 million, so 1.07% of the outstanding shares have been sold short.

Short Interest	1.33M
Short Previous Month	1.33M
Short % of Shares Out	1.07%
Short % of Float	3.42%
Short Ratio (days to cover)	4.61

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-121.19M
Pretax Income	-118.09M
Net Income	-116.91M
EBITDA	-117.66M
EBIT	-121.19M
Earnings Per Share (EPS)	-$1.70

Full Income Statement

Balance Sheet

The company has $91.93 million in cash and $31.83 million in debt, giving a net cash position of $60.10 million or $0.48 per share.

Cash & Cash Equivalents	91.93M
Total Debt	31.83M
Net Cash	60.10M
Net Cash Per Share	$0.48
Equity (Book Value)	96.66M
Book Value Per Share	0.77
Working Capital	77.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$99.66 million and capital expenditures -$229,000, giving a free cash flow of -$99.89 million.

Operating Cash Flow	-99.66M
Capital Expenditures	-229,000
Free Cash Flow	-99.89M
FCF Per Share	-$0.80

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Vor Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.25%
Shareholder Yield	-2.25%
Earnings Yield	-128.75%
FCF Yield	-110.00%

Analyst Forecast

The average price target for Vor Biopharma is $9.43, which is 1,198.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.43
Price Target Difference	1,198.72%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1